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The Kodak DT 60 system (Eastman Kodak Co., Rochester, NY), an analyzer intended for physicians' offices and satellite laboratories, is based on multilayer ifim technology (1). We evaluated the precision, accuracy, and linearity for seven different analytes over a 30-day period, using controls from the manufacturer. The method precision (CV, %) obtained with the analyzer was as follows: The Seralyzer#{174} system (Ames Division, Miles Laboratories, Elkhart, IN) is an analyzer intended for physicians' offices and satellite laboratories. After appropriate dilution, serum or plasma is placed onto test-strips, which are read by reflectance photometry (1). We evaluated precision, accuracy, and linearity for nine different analytes over a 30-day period. Different control material ("Omega I and H"; Cooper Biomedical, Fairhaven, NJ) was used for glucose, potassium, creatinine, aspartate aminotransferase (AST), and creatine kinase (CK). For hemoglobin, "Precinorm Hb" (Boehringer-Mannheim Canada, Dorval, Qu#{233}.) was used; for drugs, "Therachem I and H" (Fisher Scientific, Nepean, Ont.).
The method precision (CV, %) obtained with the analyzer was as follows: In comparing the performance of potassium, glucose, creatinine, AST, and CK, the Beckman "Astra" was used with Beckman reagents (Beckman Instruments, Brea, CA). The "Coulter Counter S Plus IV" (Coulter Electronics Inc., Hialeah, FL 33010) was used for hemoglobin comparison. For theophylline, phenytoin, and phenobarbital, either the "TDX" (Abbott Laboratories, Dallas, TX) or high-pressure liquid-chromatographic methods were used for comparison.
The range of standard curve linearity obtained for the Seralyzer methods was as follows:
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CVs were high for creatiine, creatine kinase, phenytoin, and theophylline, but method comparisons were good for all methods. We encountered no major malfunctions during the three-month period of use.
Supported by a grant from Health and Welfare, Canada. Precision, estimated by repeated measurements of a three-concentration serum-based quality control material (Lyphocheck Immunoassay Control lot, no. 11700; Bio-Rad, Anaheim, CA 92806) is summarized below. Results by the two methods, compared by using 50 serum samples submitted to our clinical laboratory, correlated well: y(Boeh.) = -1.535 + 0.906x(Abbott) (r = 0.989). There was no significant interferences from hemoglobin
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